NCT06738914

Brief Summary

A retrospective analysis of patients undergoing pancreatic operations in Landspitali University Hospital, Reykjavik, Iceland, between 2003 and 2022.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
244

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2003

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2003

Completed
19.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 12, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 18, 2024

Completed
Last Updated

December 24, 2024

Status Verified

December 1, 2024

Enrollment Period

19.9 years

First QC Date

December 12, 2024

Last Update Submit

December 19, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Severe complications

    2003-2022

  • Short-term mortality

    2003-2022

Secondary Outcomes (6)

  • Demographic, operative and postoperative data

    2003-2022

  • Oncological data and survival among patients with pancreatic and periampullary cancer

    2003-2022

  • Outcomes after pancreatic surgery among patients who underwent resection for cystic lesions

    2003-2022

  • Comparison of patients who underwent minimally invasive distal pancreatectomy during the study period to those who underwent open distal resection.

    2003-2022

  • Demographic and histopathological data as well as survival compared between patients with duodenal cancer who underwent resection and patients who did not.

    2003-2022

  • +1 more secondary outcomes

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who have undergone pancreatic resection in Iceland between 2003-2022. For the secondary outcome of duodenal cancer, patients with duodenal cancer who did not undergo resection in the same time span will also be included.

You may qualify if:

  • All patients who have undergone pancreatic resection in Iceland between 2003-2022.
  • For the secondary outcome of duodenal cancer, patients with duodenal cancer who did not undergo resection in the same time span will also be included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Johansen K, Birgisson G, Haraldsdottir KH. Early implementation of laparoscopic left-sided pancreatectomy in a tertiary low-volume hospital. Scand J Surg. 2025 Sep;114(3):334-341. doi: 10.1177/14574969251343471. Epub 2025 May 26.

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Principal investigator

Study Record Dates

First Submitted

December 12, 2024

First Posted

December 18, 2024

Study Start

January 1, 2003

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

December 24, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Not included in the ethical approval for the study.